Broadcom named strategic vendor for Walmart virtualization solutions
Investing.com - Organon Co reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Organon Co announced earnings per share of $1.32 on revenue of $1.54B. Analysts polled by Investing.com EPS of $1.17 on revenue of $1.53B.
Organon Co 's are down 26.01% and is trading at $26.35 , still down 33.25% from its 52 week high of $39.47 set on Wednesday, March 2, 2022.
Organon Co shares gained 1.62% to trade at $26.35 in intra-day trade the report.
Organon Co follows other major Healthcare sector earnings this month
Organon Co's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.9B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar